Australasian Medical & Scientific
Australasian Medical & Scientific Limited is a Dexcom company dedicated to helping people living with diabetes. With over 20 years of experience, they provide tools and support to improve quality of life for individuals with diabetes. They distribute a range of diabetes management products including Dexcom CGM systems, t:slim X2 insulin pumps, and blood glucose meters, and are actively involved in community support, sponsorships, and advancing access to diabetes technology.
Industries
Nr. of Employees
medium (51-250)
Australasian Medical & Scientific
Suite 4.01, Building A, The Park, 5 Talavera Rd, Macquarie Park, Sydney, NSW 2113, Australia
Products
Rechargeable insulin infusion pump with remote update and closed-loop support
Rechargeable insulin infusion pump platform that supports remote software updates and integration with closed-loop control algorithms for automated insulin adjustments when used with compatible glucose sensors.
Continuous glucose monitoring systems
Wearable glucose sensors and companion mobile applications providing continuous interstitial glucose measurements, trend information and alerts to support diabetes self-management and automated device functions.
Web-based CGM analytics and reporting platform
Web application presenting historical sensor data and summary metrics (time-in-range, highs/lows, estimated metrics) for review by patients and healthcare professionals to support clinical assessment.
Multi-device glucose data management platform
Web-based platform and uploader enabling transmission, storage and visualization of glucose and insulin delivery data from multiple device types for clinics and patients.
Fast-acting oral glucose solution kit
Ready-to-use oral glucose solution kit intended for immediate treatment of hypoglycaemia, formulated without common allergens and preservatives.
Rechargeable insulin infusion pump with remote update and closed-loop support
Rechargeable insulin infusion pump platform that supports remote software updates and integration with closed-loop control algorithms for automated insulin adjustments when used with compatible glucose sensors.
Continuous glucose monitoring systems
Wearable glucose sensors and companion mobile applications providing continuous interstitial glucose measurements, trend information and alerts to support diabetes self-management and automated device functions.
Web-based CGM analytics and reporting platform
Web application presenting historical sensor data and summary metrics (time-in-range, highs/lows, estimated metrics) for review by patients and healthcare professionals to support clinical assessment.
Multi-device glucose data management platform
Web-based platform and uploader enabling transmission, storage and visualization of glucose and insulin delivery data from multiple device types for clinics and patients.
Fast-acting oral glucose solution kit
Ready-to-use oral glucose solution kit intended for immediate treatment of hypoglycaemia, formulated without common allergens and preservatives.
Services
Australia-based technical support via phone and web form for monitoring sensors and insulin pumps, with specified operating hours and 24/7 support for certain pump devices.
Order processing, product enquiries, local warehousing and courier dispatch for diabetes devices and consumables within Australia.
In-person events and online educational resources for healthcare professionals and people living with diabetes, including access to an online education hub.
Provision and support of a web-based platform and uploader software enabling transmission, storage and visualization of glucose and insulin delivery data from multiple device types for clinics and patients.
Australia-based technical support via phone and web form for monitoring sensors and insulin pumps, with specified operating hours and 24/7 support for certain pump devices.
Order processing, product enquiries, local warehousing and courier dispatch for diabetes devices and consumables within Australia.
In-person events and online educational resources for healthcare professionals and people living with diabetes, including access to an online education hub.
Provision and support of a web-based platform and uploader software enabling transmission, storage and visualization of glucose and insulin delivery data from multiple device types for clinics and patients.
Expertise Areas
- Medical device distribution and supply chain
- Continuous glucose monitoring and insulin delivery
- Digital health and cloud-based diabetes data management
- Mobile health integration for insulin pumps and connected sensors
Key Technologies
- Continuous glucose monitoring (CGM) systems
- Insulin infusion pump platforms with closed-loop capability
- Mobile health applications for device control
- Cloud-based data upload and analytics platforms
News & Updates
The Dexcom G6 app has been updated to improve user experience, with rollouts for Android and iOS devices.
As of July 29, 2022, AMSL Diabetes will discontinue the sale of Dexcom G5 Mobile Transmitters and Sensors.
The government commits to providing access to continuous glucose monitoring for all people with Type 1 diabetes in Australia.
The advanced hybrid closed-loop technology for the t:slim X2 insulin pump is now available in Australia.
The Tandem t:slim Mobile app now available in Australia allows users to bolus directly from their smartphones, connecting seamlessly with the t:slim X2 insulin pump.
AMSL Diabetes signed a distribution agreement with MannKind Corporation to introduce inhaled therapies for diabetes and pulmonary hypertension in Australia.
The Dexcom G6 app has been updated to improve user experience, with rollouts for Android and iOS devices.
As of July 29, 2022, AMSL Diabetes will discontinue the sale of Dexcom G5 Mobile Transmitters and Sensors.
The government commits to providing access to continuous glucose monitoring for all people with Type 1 diabetes in Australia.
The advanced hybrid closed-loop technology for the t:slim X2 insulin pump is now available in Australia.
The Tandem t:slim Mobile app now available in Australia allows users to bolus directly from their smartphones, connecting seamlessly with the t:slim X2 insulin pump.
AMSL Diabetes signed a distribution agreement with MannKind Corporation to introduce inhaled therapies for diabetes and pulmonary hypertension in Australia.